2
Total investments
1
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2019
SIMULANDS was founded by a group of renowned clinicians, experienced engineers, entrepreneurs, and industry professionals in the field of Medical Devices and Structural Heart.
We seek to revolutionize R&D and Education in the Structural Heart space.
Simulators offer solutions that are more practical, cost-effective, and ethical versus traditional animal research practices. The 3R principles (replacement, reduction, and refinement) for more humane animal research are important guiding principles as our industry evolves. The latest technological advancements allow us to focus on what matters most – replicating procedure experiences that provide real tactile responses, and actual procedural imaging guidance with a true understanding of device performance.
We believe the role of simulators should evolve from demo tools to complete educational, certification, and recertification platforms.
SIMULANDS develops Human Grade platforms that are designed and validated according to all relevant ISO normative requirements.
Our simulators are of clinical and technical equivalence to human cardiovascular systems and meet required benchmarks of various competent authorities, ethics committees and notified bodies (CE, FDA, MDR).
We create simulators that are tailor-made, beautifully designed, simple to use and highly portable, and our joint training programs cater to a wide range of experience and knowledge levels.
Questions?
Support@Simulands.com
Experience · 4 entries
All (4)
Investments (2)
Founder (2)
Board (2)
2019
Board Member
Oct 2019
SIMULANDS was founded by a group of renowned clinicians, experienced engineers, entrepreneurs, and industry professionals in the field of Medical Devices and Structural Heart.
We seek to revolutionize R&D and Education in the Structural Heart space.
Simulators offer solutions that are more practical, cost-effective, and ethical versus traditional animal research practices. The 3R principles (replacement, reduction, and refinement) for more humane animal research are important guiding principles as our industry evolves. The latest technological advancements allow us to focus on what matters most – replicating procedure experiences that provide real tactile responses, and actual procedural imaging guidance with a true understanding of device performance.
We believe the role of simulators should evolve from demo tools to complete educational, certification, and recertification platforms.
SIMULANDS develops Human Grade platforms that are designed and validated according to all relevant ISO normative requirements.
Our simulators are of clinical and technical equivalence to human cardiovascular systems and meet required benchmarks of various competent authorities, ethics committees and notified bodies (CE, FDA, MDR).
We create simulators that are tailor-made, beautifully designed, simple to use and highly portable, and our joint training programs cater to a wide range of experience and knowledge levels.
Questions?
Support@Simulands.com
2018
O
Occlufit AG
Board Member
Dec 2018
2017
Co-Founder
Dec 2017
SV SwissVortex is the ultimate Cardiovascular Innovation Accelerator
SV SwissVortex empowers entrepreneurs, clinicians, and researchers to create and commercialize innovative cardiovascular technologies to address unmet clinical needs, improve patient outcomes and reduce the cost of care.
SV SwissVortex supports inventors in transforming their "napkin drawing" to a final product ready for clinical use.
SwissVortex projects receive one or more of the following:
• Direct access to experts: SwissVortex partners with best in class and professionals to assist with strategic assessment, engineering and design, manufacturing, regulatory guidance, quality systems, and marketing development
• Early project support: SwissVortex helps you protect your idea, refine your design, develop prototypes, achieve proof of concept and build partnerships
• Fundraising support: SwissVortex advisors analyze your technology impact and assist in the development of a pitch deck to successfully engage our network of investors at every key milestone
• Startup incorporation: SwissVortex promotes the transition from idea to company by establishing a new corporate entity for each project, forming venture backed startups in Switzerland
• Accelerated development: The Innovation Process at SwissVortex allows fast transformation of innovative technologies in final products ready for clinical use. This accelerated product development process includes design inputs, computer aided design and simulation, rapid prototyping, bench and animal testing, validation studies, manufacturing review and regulatory clearance
• Design transfer: SwissVortex ensures validation of manufacturing for the final product design by a contract manufacturer or industry partner in case of acquisition
• Product launch: SwissVortex collaborates with strategic stakeholders and market leaders to ensure a successful path towards full commercialization and healthcare improvement
2008
Chief Medical Officer and Founder
Oct 2008
Meditrial is a leading provider of clinical trial services and digital cloud-based solutions for the lifesciences industry. As a Clinical Research Organization (CRO), Meditrial is renowned as the go-to partner by companies developing breakthrough innovations that require a clearly defined path to first-in-man and pivotal clinical studies. Established in 2008, today Meditrial is a trusted resource for large corporations as well as start-ups requiring support and resources to execute trials in the Uniteef States and Europe. Headquartered in Zürich, Meditrial has offices in Berlin, Rome, London and New York.
Learm more: www.meditrial.net - www.catchtrial.com - www.mastertrial.com
Despite the everchanging regulation and increasing difficulty to obtain approval for clinical investigations, Meditrial has a remarkable record of 100% success in assisting clients to execute studies in medical centers of excellence throughout Europe and United States. Meditrial's software solutions allow customers to successfully manage large global trials and registries while monitoring the results in large number of patients.
Meditrial’s core strength lies in its clinical experts’ proficiency, alongside with its integrated digital platform for elearning, data capture and analytics. The organization provides a set of systems and tools to minimize complexity of clinical trials and regulatory approvals Meditrial is extremely proud to be one of the first—and very few—CROs certified by ISO 9001, ISO 13485 and ISO 27001 for information security.
Similar investors
Early-stage startup investors in Switzerland
Investor lists
Lists that match Monica's portfolio
- Early-stage startup investors in Switzerland676 investors





